Editorial: The immune infiltrate as a paradigm model to study the biology and novel therapeutic approaches in sarcomas

Federica Recine; Alberto Bongiovanni; Laura Mercatali; Valentina Fausti; Virginia Ferraresi; Alessandro De Vita

doi:10.3389/fendo.2023.1334519

Editorial: The immune infiltrate as a paradigm model to study the biology and novel therapeutic approaches in sarcomas

Front Endocrinol (Lausanne). 2023 Dec 4:14:1334519. doi: 10.3389/fendo.2023.1334519. eCollection 2023.

Authors

Federica Recine¹, Alberto Bongiovanni², Laura Mercatali³, Valentina Fausti², Virginia Ferraresi⁴, Alessandro De Vita⁵

Affiliations

¹ Medical Oncology Unit, Azienda Ospedaliera "San Giovanni Addolorata", Roma, Italy.
² Clinical and Experimental Oncology, Immunotherapy, Rare Cancers and Biological Resource Center, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
³ Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
⁴ Sarcomas and Rare Tumors Unit, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Regina Elena National Cancer Institute, Rome, Italy.
⁵ Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

No abstract available

Keywords: T-cell infiltration; extracellular matrix; immunotherapy; macrophages; sarcomas; tumor microenvironment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Biology
Humans
Sarcoma* / therapy
Soft Tissue Neoplasms*

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was partly supported thanks to the contribution of Ricerca Corrente by the Italian Ministry of Health.